Facilitating Surgical Choice in Patient With Chronic Hypertrophic Rhinitis Using a Patient Decision Aid
1 other identifier
interventional
158
1 country
1
Brief Summary
This study is a prospective randomized controlled trial that aims to enroll 158 patients diagnosed with chronic hypertrophic rhinitis who are candidates for inferior turbinate surgery. Participants will be randomly assigned to either the "standard group" or the "PDA group." The standard group will receive conventional shared decision-making (SDM) explanations using verbal and visual aids, while the PDA group will additionally receive a printed patient decision aid (PDA) to assist in evaluating the pros and cons of each surgical option. The study will assess patients' decision certainty and decision regret using the SURE scale and the Decision Regret Scale (DRS), respectively, administered before surgery and one month postoperatively. Surgical satisfaction and outcomes will also be evaluated using pre- and postoperative symptom questionnaires. All data will be collected and analyzed by blinded outcome assessors to ensure objectivity. This study involves no invasive procedures and is classified as a low-risk behavioral study. The primary aim is to optimize clinical decision-making processes for patients with chronic hypertrophic rhinitis considering surgical intervention in the otolaryngology setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 22, 2026
CompletedFirst Posted
Study publicly available on registry
February 27, 2026
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2027
May 14, 2026
January 1, 2026
1.2 years
February 22, 2026
May 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Decision conflicts
Mean score of decisional conflict scale by SURE test using a five-item scale with 5 questions: 1 = agree strongly, 2 = agree, 3 = neutral, 4 = disagree, 5 = disagree strongly.
On the day 1 of admission
Secondary Outcomes (1)
Decision regret
A month after surgical intervention
Other Outcomes (6)
Visual Analogue Scale for Rhinitis Symptom Severity
On the day 1 of admission and A month after surgical intervention
Symptom Impact Frequency on Daily Life
On the day 1 of admission and a month after surgical intervention
Nasal Obstruction Symptom Evaluation
On the day 1 of admission and a month after surgical intervention
- +3 more other outcomes
Study Arms (2)
Control
NO INTERVENTIONUsual counseling in the clinical encounter, when patients choose among five surgical interventions for hypertrophic rhinitis.
Patient decision aid
EXPERIMENTALA Patient Decision Aid is used in this arm in the clinical encounter. A tool designed to facilitate shared decision making when patients choose among five surgical interventions for hypertrophic rhinitis.
Interventions
The Patient Decision aid used in this project is a tool designed to facilitate shared decision making in patients with hypertrophic rhinitis. It is intended to complement counseling with health professionals and help patients become involved in decision making by making explicit the decision that needs to be made, providing information about the advantages and disadvantages of five surgical interventions, knowledge of treatment outcomes, and by clarifying personal values.
Eligibility Criteria
You may qualify if:
- Diagnosed with chronic hypertrophic rhinitis.
- Outpatients or inpatients scheduled to undergo surgical intervention.
- Aged 18 years or older and able to communicate in Chinese.
You may not qualify if:
- Presence of other structural nasal pathologies (e.g., nasal polyps, tumors).
- Patients undergoing emergency surgery.
- Individuals unable to live independently or fully comprehend the questionnaire content.
- Individuals unable to complete the questionnaires.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shuang Ho Hospital
New Taipei City, 235, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 22, 2026
First Posted
February 27, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
April 30, 2027
Study Completion (Estimated)
July 31, 2027
Last Updated
May 14, 2026
Record last verified: 2026-01